Spectrum of uterine malignancies and their oncological outcomes: a single centre experience
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20263025Keywords:
Uterine malignancy, Endometrial carcinoma, Oncological outcomes, Histopathology, Postmenopausal bleedingAbstract
Background: Endometrial carcinoma is a significant contributor to the global female cancer burden. Its incidence in India is rising because of increasing life expectancy and metabolic risk factors, although Indian outcome data remain limited. This study aimed to evaluate the spectrum of uterine malignancies and assess their oncological outcomes in an Indian cohort.
Methods: This prospective observational study was conducted at a tertiary care centre over a five-year period (2020–2025). Seventy (70) women were included following histopathological confirmation of uterine malignancy. Data on clinical presentation, histological subtype, staging, treatment, and outcomes were recorded and analysed using descriptive statistics.
Results: The mean age was in the sixth decade, with 88.6% of patients being postmenopausal. Endometrioid adenocarcinoma was the most common histological subtype (75.7%), followed by serous carcinoma (7.1%), carcinosarcoma (4.3%), and clear cell carcinoma (4.3%). Most patients presented at FIGO Stage I (61.5%) and underwent primary surgical management. Adjuvant therapy was administered in 32.9% of cases based on stage and risk factors. At a median follow-up, 72.9% of patients were alive and recurrence was observed in only 1.4%. Binary logistic regression showed that none of the individual pathological factor’s tumour grade, histology, LVSI, myometrial invasion, or cervical stromal involvement significantly predicted lymph node involvement.
Conclusion: Endometrioid carcinoma remains the predominant uterine malignancy in Indian women, typically presenting in postmenopausal women at an early stage with favourable outcomes. Given the inability of conventional pathological risk factors to reliably predict nodal involvement, comprehensive surgical staging using sentinel lymph node mapping or systematic lymphadenectomy should be considered in all cases, irrespective of initial stage.
References
Agarwal S, Melgandi W, Sonkar DR, Ansari FA, Arora S, Rathi AK, et al. Epidemiological characteristics of endometrial cancer patients treated at a tertiary health center in National Capital Territory of India. J Cancer Res Ther. 2023;19(2):452-6.
Koppikar S, Oaknin A, Babu KG, Lorusso D, Gupta S, Wu LY, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer. ESMO Open. 2023;8(1):100774.
Sivakumari S, Rajaraman R, Subbiah S. Uterine sarcoma: the Indian scenario. Indian J Surg Oncol. 2015;6(3):232-6.
Plentz TBSF, Candido EC, Dias LF, Toledo MCS, Vale DB, Teixeira JC. Diagnosis, treatment and survival of uterine sarcoma: a retrospective cohort study of 122 cases. Mol Clin Oncol. 2020;13(6):81.
Bafna U, Bhosale S, Mahantshetty U. Real-world outcomes and prognostic factors in uterine leiomyosarcoma from a tertiary cancer centre in India. J Clin Oncol. 2022;40(16):17620.
Nusrath S, Bafna S, Rajagopalan R, Thammineedi SR, Raju KVVN, Patnaik SC, et al. Uterine sarcomas: experience from a tertiary cancer care center from India. Indian J Surg Oncol. 2019;10(2):342-9.
Sathishkumar K, Sankarapillai J, Mathew A, Nair RA, Gangane N, Khuraijam S, et al. Survival of Patients with Cervical Cancer in India—Findings from 11 Population Based Cancer Registries under National Cancer Registry Programme. Lancet. 2023;24:100296.
Halder P, Dixit J, Gupta N, Mehra N, Singh A, Malhotra P, et al. Access to timely cancer treatment initiation in India: extent, determinants and trends. Lancet Reg Health Southeast Asia. 2024;32:100514.
Ramamoorthy T, Sathishkumar K, Das P, Sudarshan KL, Mathur P. Epidemiology of human papillomavirus related cancers in India: findings from the National Cancer Registry Programme. Ecancermedicalscience. 2022;16:1444.
Gangane NM, Patil BU, Ghongade PV. Ovarian cancer: a report from a population-based cancer registry at central rural India. J Cancer Res Ther. 2023;19(4):857-62.
Mailankody S, Bajpai J, Budukh A, Swaminathan R, Dikshit R, Dhimal M, et al. Epidemiology of rare cancers in India and South Asian countries - remembering the forgotten. Lancet Reg Health Southeast Asia. 2023;12:100168.
Babu J, Pulinilkunnathil RG, Kumar BR. An epidemiological assessment of endometrial carcinoma including demographics and histopathological correlation, from a tertiary care teaching hospital in South India. J Evid Based Med Healthc. 2021;8(30):2751-6.
Prem A, Thekkeveettil M, Mathew RS, Cyriac ME, Sheeja S, Joseph AN. Clinicopathological profile of carcinoma endometrium in a single institution of Kerala, India. J Midlife Health. 2025;16(1):96-102.
Pradhan R, Roy Biswas R, Mondal S, Mukherjee U. Immunohistochemical diversity of endometrial carcinoma and their implications in prognosis: a prospective clinicopathological study in a tertiary care hospital of Eastern India. J Obstet Gynaecol India. 2025;75(1):166-72.
Philips AO, Kaur T, Garg S, Sharma I, Anand M, Batta N, et al. Clinical profile and outcomes of patients with endometrial cancer from Northwest India: a retrospective study. Cancer Res Stat Treat. 2024;7(4):403-9.
Cusano E, Myers V, Samant R, Sudai T, Keller A, Le T, et al. Prognostic significance of lymphovascular space invasion in the absence of lymph node metastases in early-stage endometrial cancer. Int J Gynecol Cancer. 2018;28(5):890-4.
Dai Y, Dong Y, Cheng Y, Hou H, Wang J, Wang Z, et al. Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center. J Gynecol Oncol. 2020;31(3):27.
Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 study. J Clin Oncol. 2012;30(7):695-700.
Downloads
Published
How to Cite
Issue
Section
